We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-5.88%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$315M
AUM Growth
+$48.5M
Cap. Flow
+$47.4M
Cap. Flow %
15.08%
Top 10 Hldgs %
69.9%
Holding
69
New
7
Increased
7
Reduced
7
Closed
20

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$30M
2
SNY icon
Sanofi
SNY
+$15.9M
3
COR icon
Cencora
COR
+$14.2M
4
SNN icon
Smith & Nephew
SNN
+$5.85M
5
SKIN icon
SkinHealth Systems
SKIN
+$3.75M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$10.4M
2
BIIB icon
Biogen
BIIB
+$7.32M
3
MDT icon
Medtronic
MDT
+$7.18M
4
SGHT icon
Sight Sciences
SGHT
+$6.52M
5
NTUS
Natus Medical Inc
NTUS
+$6.26M

Sector Composition

Rank Sector Weight
1 Healthcare 63.89%
2 Financials 7.31%
3 Consumer Staples 2.47%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
51
Bausch Health
BHC
$2.24B
-6,700
Closed -$46.5K
BIIB icon
52
Biogen
BIIB
$30.4B
-35,900
Closed -$7.32M
CAH icon
53
Cardinal Health
CAH
$56.5B
-119,061
Closed -$6.22M
BGMS
54
Bio Green Med Solution Inc
BGMS
$5.74M
-126
Closed -$491K
DTIL icon
55
Precision BioSciences
DTIL
$195M
-33,633
Closed -$1.61M
HCA icon
56
HCA Healthcare
HCA
$89.3B
-61,953
Closed -$10.4M
MDT icon
57
Medtronic
MDT
$110B
-80,000
Closed -$7.18M
SGHT icon
58
Sight Sciences
SGHT
$361M
-724,944
Closed -$6.52M
THC icon
59
Tenet Healthcare
THC
$21B
-105,000
Closed -$5.52M
VKTX icon
60
Viking Therapeutics
VKTX
$3.95B
-999,829
Closed -$2.89M
XENE icon
61
Xenon Pharmaceuticals
XENE
$6.26B
-16,368
Closed -$498K
PRDS
62
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
-315,564
Closed -$969K
ISO
63
DELISTED
IsoPlexis Corporation Common Stock
ISO
-407,102
Closed -$879K
ALBO
64
DELISTED
Albireo Pharma Inc
ALBO
-58,556
Closed -$1.16M
NTUS
65
DELISTED
Natus Medical Inc
NTUS
-190,956
Closed -$6.26M
HZNP
66
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-40,000
Closed -$3.19M
HSKA
67
DELISTED
Heska Corp
HSKA
-39,566
Closed -$3.74M
BHVN
68
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-35,000
Closed -$5.1M
INBX
69
DELISTED
Inhibrx, Inc. Common Stock
INBX
-365,210
Closed -$4.14M

Similar funds

Sio Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sio Capital Management held 69 positions worth $315M, up 18% from $266M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Sio Capital Management deployed $47.4M of net new capital in Q3 2022, opening 7 new positions and adding to 7 existing holdings. Its largest new stake was GSK: 790,600 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 84% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Inari Medical, Inc. Common Stock, an estimated $4.09M trimmed.

  • Sio Capital Management's largest Q3 2022 buy was GSK: 790,600 shares worth $23.3M.
  • Sio Capital Management added most to Cencora in Q3 2022, an estimated $14.2M increase.
  • Sio Capital Management's biggest Q3 2022 reduction was Inari Medical, Inc. Common Stock, cutting an estimated $4.09M.
  • Sio Capital Management fully exited HCA Healthcare in Q3 2022, selling an estimated $10.4M.
  • Sio Capital Management's ten largest holdings make up 70% of its $315M portfolio in Q3 2022.
  • Sio Capital Management opened 7 new positions and closed 20 in Q3 2022.
  • Sio Capital Management's portfolio value rose 18% quarter-over-quarter to $315M.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.